School of Medicine


Showing 601-700 of 723 Results

  • Frank E. Stockdale

    Frank E. Stockdale

    Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsLaboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth

  • Han Sun

    Han Sun

    Postdoctoral Scholar, Genetics
    Biostatistician 2, Pediatrics - Endocrinology

    BioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.

    After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes.

  • Louise Y Sun

    Louise Y Sun

    Professor of Anesthesiology, Perioperative and Pain Medicine

    BioDr. Louise Sun recently joined the Stanford University School of Medicine as the Chief of Cardiothoracic Anesthesiology and Professor of Anesthesiology, Perioperative and Pain Medicine. She is an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Toronto. Prior to this, she was an Associate Professor of Anesthesiology and Epidemiology, Director of Big Data and Health Bioinformatics Research at the University of Ottawa Heart Institute, and a Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa.

    Dr. Sun received her medical degree from McMaster University. She completed her anesthesiology residency at the University of Ottawa and her Masters of Science in Epidemiology at the Harvard School of Public Health, followed by a clinical and research fellowship in cardiac anesthesia at the University of Toronto. She then joined the Division of Cardiac Anesthesiology at the University of Ottawa Heart Institute and was cross appointed as an ICES faculty member.

    Dr. Sun’s areas of clinical focus are hemodynamic monitoring and heart failure. Her methodologic areas of focus are the conduct of population-based cohort studies using large healthcare databases; predictive analytics; sex and gender epidemiology; patient engagement; innovative methods for data processing and warehousing; and software and applications development. Her research leverages big data and digital technology to bridge key gaps in the delivery of care and outcomes for patients with heart failure and/or undergoing cardiovascular interventions, zooming in on sex/gender and personalized care. She holds several patents and collaborates with health authorities and policy makers to evaluate and report on models of cardiac healthcare delivery.

    Dr. Sun is active in the scientific community. She sits on a number of US, Canadian and international editorial boards and scientific and grant review committees, and collaborates nationally and internationally on a variety of population health and data science initiatives. Her patient-centered research program aims to improve access to care and outcomes, focusing on personalized risk stratification and long-term, patient-defined outcomes. She has authored over 100 peer-reviewed papers and published in leading clinical journals including JAMA, JAMA Cardiology, JAMA Internal Medicine, Circulation, JACC, Diabetes Care, and Anesthesiology. Her research program has been well funded by the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Canada, and the Ontario Ministry of Health.

  • Katrin J Svensson

    Katrin J Svensson

    Assistant Professor of Pathology

    Current Research and Scholarly InterestsMolecular metabolism
    Protein biochemistry
    Cell biology and function
    Animal physiology

  • James Swartz

    James Swartz

    James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering

    Current Research and Scholarly InterestsProgram Overview

    The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
    Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
    To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
    To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
    More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.

  • Ali Bin Syed

    Ali Bin Syed

    Clinical Assistant Professor, Radiology - Pediatric Radiology

    BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Director of MRI for Stanford Medicine Children's Health. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher, collaborating with fellow engineers and scientists at Stanford to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.

  • Daniel Sze, MD, PhD

    Daniel Sze, MD, PhD

    Professor of Radiology (Interventional Radiology)

    Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections

  • C. Barr Taylor

    C. Barr Taylor

    Member, Cardiovascular Institute

    Current Research and Scholarly InterestsDr. Taylor is developing and evaluating innovative electronic and computer-assisted programs to make treatments, proven effective for treating various lifestyle and psychosocial problems, more cost-effective and available. He is also developing new models of evidence-based psychiatry care for eating, anxiety and depressive disorders.

  • Jeffrey Teuteberg

    Jeffrey Teuteberg

    Professor of Medicine (Cardiovascular Medicine)

    BioHe is currently a Professor of Medicine at Stanford where he serves as the Section Chief of Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. He sees patients both in the clinic and in the hospital who have advanced heart failure or who have received cardiac transplantation or mechanical circulatory support.

    His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018.

  • Avnesh Thakor

    Avnesh Thakor

    Associate Professor of Radiology (Pediatric Radiology)

    Current Research and Scholarly InterestsInterventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular, percutaneous, endoluminal, and even using device implantation approaches

  • Lindsay Thomas, RN, MS, CNS

    Lindsay Thomas, RN, MS, CNS

    Affiliate, Medicine - Med/Cardiovascular Medicine

    BioMs. Lindsay Thomas earned her BA in Integrative Biology from UC Berkeley in 2003 and her RN and MS from UCSF in 2006 and 2009 respectively. She completed a Double Master’s in Cardiovascular Nursing and Genomics and is a board certified clinical nurse specialist in critical care nursing. She joined the Stanford Interventional Cardiology Team in 2011 where she has pioneered the advanced practice nursing role in the cath lab and been a leader in the development of the Left Atrial Appendage Closure program. She serves as adjunct faculty for the UCSF graduate nursing program and is the co-chair of the Northern California Chapter of the Preventative Cardiovascular Nurses Association. Lindsay specializes in treating and caring for patients with established coronary artery disease and cardiovascular risk factors; she strives to provide excellent patient care and education to optimize a heart healthy life style to promote wellness with use of medications and invasive procedures when life style alone is not enough to achieve desired results. When not working Lindsay is an outdoor and exercise enthusiast, who enjoys participating in various endurance activities and has completed several triathlons. She also enjoys reading and discussions with her book club, going to the theater, and spending quality time with her friends and family.

  • Lu Tian

    Lu Tian

    Professor of Biomedical Data Science and, by courtesy, of Statistics

    Current Research and Scholarly InterestsMy research interest includes
    (1) Survival Analysis and Semiparametric Modeling;
    (2) Resampling Method ;
    (3) Meta Analysis ;
    (4) High Dimensional Data Analysis;
    (5) Precision Medicine for Disease Diagnosis, Prognosis and Treatment.

  • Seda Tierney

    Seda Tierney

    Professor of Pediatrics (Cardiology)

    Current Research and Scholarly InterestsAssessment of vascular health in children by non-invasive modalities

    Exercise interventions in children with congenital and acquired heart disease

    Use of telehealth to deliver interventions to children with congenital and acquired heart disease

    Parentally-acquired echocardiograms

    Quality Improvement in Pediatric Echocardiography

    Echocardiography and outcomes in congenital heart disease

  • Kenneth Tran, MD

    Kenneth Tran, MD

    Clinical Assistant Professor, Surgery - Vascular Surgery

    BioDr. Tran is a board-certified vascular surgeon in the Vascular and Endovascular Surgery Division at Stanford Health Care. He is also a clinical assistant professor of surgery at the Stanford University School of Medicine.

    Dr. Tran graduated with high honors from the University of Virginia School of Engineering in 2011 and earned his medical degree from Stanford University School of Medicine in 2016. He completed his surgical training at Stanford University School of Medicine, culminating in his completion of the Vascular Surgery Integrated Residency at Stanford in 2023. During his residency, Dr. Tran completed a two-year NIH-funded fellowship under the mentorship of Dr. Alison Marsden. This fellowship focused on using computer simulations of blood flow to enhance the treatment of vascular diseases.

    Dr. Tran's research pursuits center on expanding the use of computational simulation techniques to understand changes in blood flow after different vascular treatments. He also has a special interest in using customized grafts to repair complex aortic conditions. Dr. Tran studies blood flow and clinical outcomes after treatment with these customized aortic grafts.

    He has published his work in numerous prestigious peer-reviewed journals, including the Journal of Vascular Surgery, JAMA Surgery, and the European Journal of Vascular and Endovascular Surgery. He has presented at the podium at numerous national and international conferences. Dr. Tran has also received multiple research awards, including the Vascular and Endovascular Surgery Society’s Medtronic Resident Research Award, the best resident presentation at the Swiss Society for Vascular Diseases, and the Young Researcher Prize at the European Symposium on Vascular Biomaterials. He also co-authored a chapter in the book Complications in Endovascular Surgery.

    Dr. Tran’s clinical interests include the entire spectrum of vascular surgery, including but not limited to:
    • Traditional and minimally invasive strategies for aortic aneurysm repair
    • Traditional, minimally invasive, and hybrid methods for managing peripheral vascular disease
    • Management of cerebrovascular disease, including carotid angioplasty/stenting, transcarotid artery revascularization (TCAR), and conventional carotid surgery
    • Comprehensive dialysis access creation
    • Treatment of venous reflux

  • Jennifer Tremmel

    Jennifer Tremmel

    Susan P. and Riley P. Bechtel Medical Director and Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Tremmel studies sex differences in cardiovascular disease. Current research projects include evaluating sex differences in coronary pathophysiology, young patients presenting with myocardial infarction, the impact of stress on anginal symptoms, chronic total coronary occlusions, and vascular access site complications.

  • Stephen Tsai

    Stephen Tsai

    Professor (Research) of Aeronautics and Astronautics, Emeritus

    BioProfessor Tsai's research interest is in the development of design methodology of composite materials and structures. As an emerging technology, composite materials offer unique performances for structures that combine light weight with durability. Keys to the successful utilization of composite materials are predictability in performance and cost effective design of anisotropic, laminated structures. Current emphasis is placed on the understanding of failure modes, and computer simulation for design and cost estimation.

  • Philip S. Tsao, PhD

    Philip S. Tsao, PhD

    Professor (Research) of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.

  • Jason V. Tso, MD

    Jason V. Tso, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Tso is a board-certified cardiologist with the Sports Cardiology Program and the Center for Inherited Cardiovascular Disease. He serves as medical director of the Sports Cardiology Program and is a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine.

    As a noninvasive cardiologist with clinical expertise in sports cardiology, Dr. Tso specializes in treating physically active patients. He cares for recreational weekend warriors, elite and professional athletes, and all those in between.

    He has experience caring for athletes from professional sports teams and multiple National Collegiate Athletic Association (NCAA) Division I universities. Dr. Tso currently performs cardiac screening and consultations for Bay Area professional sports teams and the NCAA Division I athletes of Stanford University Athletics.

    Dr. Tso’s research interests include cardiovascular health and adaptation in athletes. He has spent years studying American-style football players and Masters endurance athletes. He has presented his research at multiple national meetings, including the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions, and the national meeting of the Heart Failure Society of America.

    Dr. Tso’s research has been published in multiple peer-reviewed journals, including the Journal of the American Heart Association, the European Journal of Preventive Cardiology, and the British Journal of Sports Medicine. He also regularly serves as a reviewer for several cardiology and sports medicine journals.

  • PJ Utz

    PJ Utz

    Professor of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.

  • Randall Vagelos, MD

    Randall Vagelos, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
    IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions.

  • Hannah Valantine

    Hannah Valantine

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.

  • Pieter van der Starre

    Pieter van der Starre

    Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
    Neurophysiology and Monitoring,
    Transesophageal Echocardiography

  • Roxanna Van Norman

    Roxanna Van Norman

    Sr. Marketing Manager, Cardiothoracic Surgery

    Current Role at StanfordSr. Marketing Manager, Stanford University School of Medicine, Department of Cardiothoracic Surgery

  • Anubodh Sunny Varshney

    Anubodh Sunny Varshney

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor in the section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also an Investigator in the Cardiovascular Outcomes, Policy, & Implementation Research Group (https://www.copirgroup.com/) where he works to identify patient groups that have ongoing unmet medical needs, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence clinical adoption of novel drug and device therapies.

    Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.

    Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.

  • Shreyas Vasanawala, MD/PhD

    Shreyas Vasanawala, MD/PhD

    William R. Brody Professor of Pediatric Radiology and Child Health

    Current Research and Scholarly InterestsOur group is focused on developing new fast and quantitative MRI techniques.

  • Ross Daniel Venook

    Ross Daniel Venook

    Senior Lecturer of Bioengineering

    BioRoss is a Senior Lecturer in the Bioengineering department and he is the Associate Director for Engineering at the Stanford Byers Center for Biodesign.

    Ross primarily co-leads undergraduate laboratory courses at Stanford—an instrumentation lab (BIOE123) and an open-ended capstone design lab sequence (BIOE141A/B)—and he supports other courses and runs hands-on workshops in the areas of prototyping and systems engineering related to medical device innovation. He enjoys the unique challenges and constraints offered by biomedical engineering projects, and he delights in the opportunity for collaborative learning in a problem-solving environment.

    An Electrical Engineer by training (Stanford BS, MS, PhD), Ross’ graduate work focused on building and applying new types of MRI hardware for interventional and device-related uses. Following a Biodesign Innovation fellowship, Ross helped to start the MRI safety program at Boston Scientific Neuromodulation, where he worked for 15 years to enable safe MRI access for patients with implanted medical devices--including collaboration across the MRI safety community to create and improve international standards.

  • Carlos Vera

    Carlos Vera

    Postdoctoral Scholar, Cardiovascular Institute

    BioCarlos obtained his B.S. in Industrial Biotechnology from the University of Puerto Rico at Mayaguez. He received his PhD from the University of Colorado at Boulder working with Dr. Leslie Leinwand on myosin myopathies. His dissertation focused on analyzing the effects on myosin's cross-bridge cycle from mutations associated to Hypertrophic (HCM) and Dilated (DCM) cardiomyopathies. For his postdoc he will focus on disease mechanisms that can influence severity.

  • Abraham Verghese, MD, MACP

    Abraham Verghese, MD, MACP

    Linda R. Meier and Joan F. Lane Provostial Professor

    Current Research and Scholarly InterestsMy interest is in clinical skills and the bedside exam, both in its technical aspects, but also in the importance of the ritual and what is conveyed by the physician's presence and technique at the bedside. This work interests me from an educational point of view, and also from the point of view of ethnographic studies related to rituals and how they transform the patient-physician relationship. Recently we have become interested in medical error as a result of oversights in the bedside exam.

  • José Vilches-Moure, DVM, PhD

    José Vilches-Moure, DVM, PhD

    Assistant Professor of Comparative Medicine

    BioDr. José G. Vilches-Moure, DVM, PhD, Assistant Professor, received his DVM degree from Purdue University in Indiana in 2007. He completed his residency training in Anatomic Pathology (with emphasis in pathology of laboratory animal species) and his PhD in Comparative Pathology at the University of California-Davis. He joined Stanford in 2015, is the founder and current Faculty Director for Comparative and Experimental Pathology Post-doctoral Fellowship, the current Faculty Director of the Master of Laboratory Animal Science (MLAS) Graduate Program, and is the past Director of the Animal Histology Services (AHS; 2015-2022). Dr. Vilches-Moure is a diplomate of the American College of Veterinary Pathologists, and his collaborative research interests include refinement of animal models, cancer biology and early cancer detection techniques, cardiac development and pathology, developmental pathology, and host-pathogen interactions. His teaching interests include comparative anatomy/histology, general pathology, comparative pathology, and pathology of laboratory animal species.

  • Melissa Ann Vogelsong

    Melissa Ann Vogelsong

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Vogelsong is a Clinical Assistant Professor at Stanford University where she is involved in clinical work, education, and research. She completed her residency and dual fellowship training in Adult Cardiothoracic Anesthesia and Critical Care Medicine at Stanford and now attends in the Cardiovascular Intensive Care Unit (CVICU) and cardiac ORs. This clinical work continuously reveals the ability of modern medicine to overcome seemingly insurmountable injury and illness, yet she believes that optimal care helps a patient to return to the highest level of functioning possible. Thus her research centers around finding ways to optimize the quality of life for survivors of critical illness, particularly those supported on mechanical circulatory support and those who have suffered cardiac arrest. She has received funding from the Zoll Foundation and serves as a member of the American Heart Association's Emergency Cardiovascular Care Science Subcommittee.

    Additionally, Dr. Vogelsong serves as Associate Medical Director for Life Flight, Stanford's air medical transport service and the only hospital-based flight program in California. She is actively engaged in efforts to enhance the provision of critical care within Stanford Hospital, and serves on multiple committees including the Medical Emergency Response Committee (MERC), ECMO Task Force, and CVICU Continuous Quality Improvement group.

    When not at work, Dr. Vogelsong is a huge fan of life in California and can often be found hiking, on a mountain bike, in her Sprinter van, or talking to her many goats, llamas, and horses.

  • Nirali Vora

    Nirali Vora

    Clinical Professor, Neurology & Neurological Sciences

    BioDr. Nirali Vora is a Clinical Professor of Neurology and Neurological sciences at Stanford University. She is board certified in Adult Neurology and Vascular Neurology after completing her residency and advanced fellowship training at Stanford. She provides comprehensive care for all stroke patients, as well as hospitalized adults with acute or undiagnosed neurological conditions. She specializes in treating vascular disorders including TIA, vasculitis, dissection, venous thrombosis, and undetermined or “cryptogenic” causes of stroke.

    Dr. Vora directs the Stanford Global Health Neurology program, through which she collaborated to start the first stroke unit in Zimbabwe and gained experience in HIV neurology and other neuro-infectious diseases. Additional research interests include stroke prevention, TIA triage, eliminating disparities in health care, and neurology education. She is also the Director of the Stanford Adult Neurology Residency Program.

  • Shannon Walters

    Shannon Walters

    Executive Technical Director, Radiology - Diagnostic Radiology

    Current Role at StanfordI consider myself an innovation enabler and workflow optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, I work closely with healthcare providers, researchers, and educators to enable effective health visualization. Recent innovations are of particular interest to me; such as 3D Printing, immersive volumetric visualization, clinical implementation of validated AI algorithms, and the general concept of reporting concise changes over time.

  • Hanjay Wang

    Hanjay Wang

    Resident in Cardiothoracic Surgery - Thoracic Surgery
    Affiliate, Department Funds

    Current Research and Scholarly InterestsPrecision surgery: patient-specific bypass grafting and valve repair strategies
    Autonomous robotic surgery
    Photosynthetic therapies to circumvent myocardial ischemia
    Collateral artery formation as protection against myocardial infarction
    Angiogenesis and myocardial regeneration to prevent heart failure
    Tissue engineering to limit ventricular remodeling
    Understanding the biomechanics of injured and failing hearts

  • Paul  J. Wang, MD

    Paul J. Wang, MD

    John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering

    Current Research and Scholarly InterestsDr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang is committed to addressing disparities in care and is actively involved in increasing diversity in clinical trials.

  • Shan X. Wang

    Shan X. Wang

    Leland T. Edwards Professor in the School of Engineering and Professor of Electrical Engineering and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)

    Current Research and Scholarly InterestsShan Wang was named the Leland T. Edwards Professor in the School of Engineering in 2018. He directs the Center for Magnetic Nanotechnology and is a leading expert in biosensors, information storage and spintronics. His research and inventions span across a variety of areas including magnetic biochips, in vitro diagnostics, cancer biomarkers, magnetic nanoparticles, magnetic sensors, magnetoresistive random access memory, and magnetic integrated inductors.

  • Tao Wang (王韬)

    Tao Wang (王韬)

    Research Scientist, Genetics

    Current Role at StanfordProject Manager & Scientific Co-lead, PsychENCODE Project
    Lead, AI & HPC toolkits for Biomedical Sciences
    ENCODE and PsychENCODE Project Data Manager
    Research Scientist, US Veteran Affairs Hospital

  • Brian Wayda

    Brian Wayda

    Postdoctoral Scholar, Cardiovascular Medicine

    Current Research and Scholarly InterestsHeart transplant policy and outcomes, cost-effectiveness, mathematical modeling

  • Ann Weinacker

    Ann Weinacker

    Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.

  • Irving Weissman

    Irving Weissman

    Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology

    Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.

  • Chad S. Weldy, M.D., Ph.D.

    Chad S. Weldy, M.D., Ph.D.

    Instructor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsAs a physician-scientist in the lab of Dr. Quertermous I work to understand the genetic basis of cardiovascular disease and the transcriptional and epigenomic mechanisms of atherosclerosis. My work is focused across four main areas of cardiovascular genetics and mechanisms of coronary artery disease and smooth muscle biology:
    1.Vascular smooth muscle specific ADAR1 mediated RNA editing of double stranded RNA and activation of the double stranded RNA receptor MDA5
    2.Defining on single cell resolution the cellular and epigenomic features of human vascular disease across vascular beds of differing embryonic origin
    3.CRISPRi screening with targeted perturb seq (TAPseq) to identify novel CAD genes in human coronary artery smooth muscle cells
    4.Investigation of the epigenetic and molecular basis of coronary artery disease and smooth muscle cell transition in mice with conditional smooth muscle genetic deletion of CAD genes Pdgfd and Sox9

    My work with Dr. Quertermous is focused on discovery of causal mechanisms of disease through leveraging human genetics with sophisticated molecular biology, single cell sequencing technologies, and mouse models of disease. This work attempts to apply multiple scientific research arms to ultimately lead to novel understandings of vascular disease and discover important new therapeutic approaches for drug discovery.

    Grant funding received for this work:

    Mentored Clinical Scientist Research Career Development Award (K08)(NIH/NHLBI, 1 K08 HL167699-01), Submitted June, 2022. PI: Weldy, Chad
    •Title of proposal: “ADAR Mediated RNA editing is a causal mechanism in coronary artery disease”.
    •Pending 08/01/2023 Start date
    •$850,000 over 5 years

    Career Development Award, American Heart Association (AHA CDA)(23CDA1042900), July, 2023 – June, 2026. PI: Weldy, Chad
    •Title of proposal: “Linking RNA editing to coronary artery calcification and disease”
    •Activation on 07/01/2023
    •$231,000 over three years

    NIH Loan Repayment Program (LRP) Award (NIH/NHLBI) Renewal Award, July, 2023. PI: Weldy, Chad
    •Title of proposal: “RNA editing is a causal mechanism of coronary artery disease”

    Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (NIH/NHLBI, 1 F32 HL160067-01), July, 2021. PI: Weldy, Chad
    • Titled, “A transcriptional network which governs smooth muscle transition is mediated by causal coronary artery disease gene PDGFD”
    •*Received perfect score with impact score 10, 1st percentile

    NIH Loan Repayment Program (LRP) Award (NIH/NHLBI), July, 2021. PI: Weldy, Chad
    •Title of proposal: "Single cell transcriptomic and epigenomic features of human atherosclerosis".
    •This will award up to $100,000 towards student loans over the next 24 months with opportunity for renewal after 24 months.

  • Marius Wernig

    Marius Wernig

    Professor of Pathology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine

  • Cornelia Weyand

    Cornelia Weyand

    Professor of Medicine (Immunology and Rheumatology), Emerita

    Current Research and Scholarly InterestsAutoimmunity
    Chronic inflammatory disease
    Metabolic control of immune function

  • Matthew Wheeler

    Matthew Wheeler

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.

  • Jeffrey J. Wine

    Jeffrey J. Wine

    Benjamin Scott Crocker Professor of Human Biology, Emeritus

    Current Research and Scholarly InterestsThe goal is to understand how a defective ion channel leads to the human genetic disease cystic fibrosis. Studies of ion channels and ion transport involved in gland fluid transport. Methods include SSCP mutation detection and DNA sequencing, protein analysis, patch-clamp recording, ion-selective microelectrodes, electrophysiological analyses of transmembrane ion flows, isotopic metho

  • Virginia D. Winn, MD, PhD

    Virginia D. Winn, MD, PhD

    Associate Professor of Obstetrics and Gynecology (Reproductive and Stem Cell Biology)

    Current Research and Scholarly InterestsThe Winn Laboratory seeks to understand the unique biological mechanisms of human placentation. While the placenta itself is one of the key characteristics for defining mammals, the human placenta is different from most available animal models: it is one of the most invasive placentas, and results in the formation of an organ comprised of cells from both the fetus and the mother. In addition to this fascinating chimerism, fetal cells are deeply involved in the remodeling of the maternal vasculature in order to redirect large volumes of maternal blood to the placenta to support the developing fetus. As such, the investigation of this human organ covers a large array of biological processes, and deals not only with understanding its endocrine function, but the physiologic process of immune tolerance, vascular remodeling, and cellular invasion.

  • Paul H. Wise, MD, MPH

    Paul H. Wise, MD, MPH

    Richard E. Behrman, MD, Professor of Child Health and Society, Professor of Health Policy and Senior Fellow at the Freeman Spogli Institute for International Studies
    On Leave from 02/01/2024 To 12/20/2024

    Current Research and Scholarly InterestsHe is a health policy and outcomes researcher whose work has focused on children's health; health-outcomes disparities by race, ethnicity and socioeconomic status; the interaction of genetics and the environment as these factors influence child and maternal health; and the impact of medical technology on disparities in health outcomes.

  • Ronald Witteles

    Ronald Witteles

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly Interests1) Amyloidosis -- Optimizing diagnosis/therapy and discovering new treatments
    2) CardioOncology -- Understanding, treating, and preventing cancer therapy-induced cardiotoxicity
    3) Sarcoidosis -- Exploring novel diagnostic modalities and determining optimal treatment, with a focus on cardiac sarcoidosis

  • Wing Hung Wong

    Wing Hung Wong

    Stephen R. Pierce Family Goldman Sachs Professor of Science and Human Health and Professor of Biomedical Data Science

    Current Research and Scholarly InterestsCurrent interest centers on the application of statistics to biology and medicine. We are particularly interested in questions concerning gene regulation, genome interpretation and their applications to precision medicine.

  • Jennifer Woo, MD

    Jennifer Woo, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor, Pediatrics - Cardiology

    BioDr. Woo is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. She is also a clinical assistant professor in the Divisions of Cardiovascular Medicine and Pediatric Cardiology at Stanford University School of Medicine.

    She diagnoses and treats a range of cardiovascular diseases, with a focus on adult congenital heart disease. Dr. Woo has Level III training with the National Board of Echocardiography, a certification that recognizes her experience in complex cardiac imaging. She also has specialized expertise in cardiac MRI. Each of her patients receives a personalized, comprehensive care plan delivered with compassion.

    Dr. Woo is heavily involved in adult congenital heart disease research. She has a particular interest in imaging and heart failure in adults with congenital heart disease. She has received grant funding for her work, including from the Adult Congenital Heart Association. The National Institutes of Health awarded granted her the Ruth L. Kirschstein National Research Service Award.

    She has published research in several peer-reviewed journals, such as the Journal of the American College of Cardiology and Pediatric Cardiology. Dr. Woo has presented her findings at regional and national meetings, including the Adult Congenital Heart Disease Bay Area Conference and the International Symposium on Adult Congenital Heart Disease.

    Dr. Woo is a member of the Adult Congenital Heart Association, American College of Cardiology, American Heart Association, and American Society of Echocardiography.

  • Joseph Woo, MD, FACS, FACC, FAHA

    Joseph Woo, MD, FACS, FACC, FAHA

    Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering

    BioDr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery.

    He chairs the Stanford Health Cardiothoracic Surgery Department. He is the Norman E. Shumway Professor of Cardiothoracic Surgery and holds a courtesy appointment in the Department of Bioengineering.

    Dr. Woo is a board-certified, fellowship-trained heart surgeon with an active clinical practice of more than 300 pump cases per year. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, cardiopulmonary transplantation, and minimally invasive surgery.

    He has advanced these fields by developing innovative surgical procedures. He serves as principal investigator on two studies funded by National Institutes of Health (NIH) grants. One explores stem cells, angiogenesis, tissue engineering, and valvular biomechanics. Dr. Woo has received NIH funding for this study continuously since 2004.

    He has served as primary investigator for clinical device trials. He also has been the primary investigator for translational scientific clinical trials entailing administration of stem cells during coronary artery bypass grafting and left ventricular arterial device (LVAD) implantation.

    Dr. Woo has co-authored more than 400 articles in peer-reviewed publications.
    Dr. Woo serves on the board of directors of the American Association for Thoracic Surgery (AATS). He is the president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia.

    He is a member of the Society of Thoracic Surgeons, International Society for Minimally Invasive Cardiac Surgery, International Society for Heart & Lung Transplantation, International Society for Heart Research, and other professional societies.

  • Joseph  C. Wu, MD, PhD

    Joseph C. Wu, MD, PhD

    Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology

    Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.

  • Sean M. Wu

    Sean M. Wu

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.

  • Joanna Wysocka

    Joanna Wysocka

    Lorry Lokey Professor and Professor of Developmental Biology

    Current Research and Scholarly InterestsThe precise and robust regulation of gene expression is a cornerstone for complex biological life. Research in our laboratory is focused on understanding how regulatory information encoded by the genome is integrated with the transcriptional machinery and chromatin context to allow for emergence of form and function during human embryogenesis and evolution, and how perturbations in this process lead to disease.

  • Fan Yang

    Fan Yang

    Associate Professor of Orthopaedic Surgery and of Bioengineering

    Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.

  • Phillip C. Yang, MD

    Phillip C. Yang, MD

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.

  • Yunzhi Peter Yang

    Yunzhi Peter Yang

    Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering

    Current Research and Scholarly InterestsYang’ lab's research interests are in the areas of bio-inspired biomaterials, medical devices, and 3D printing approaches for re-creating a suitable microenvironment for cell growth and tissue regeneration for musculoskeletal disease diagnosis and treatment, including multiple tissue healing such as rotator cuff injury, orthopedic diseases such as osteoporosis and osteonecrosis, and orthopedic traumas such as massive bone and muscle injuries.

  • Alan Yeung, MD

    Alan Yeung, MD

    Li Ka Shing Professor in Cardiology

    Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.